Despite overall selling, FIIs staying put in these stocks
Firstpost did a quick analysis to bring to you 56 companies in which FIIs increased their stakes in the past four quarters. Not only that, around 40 percent of these companies have also seen an...
View ArticleTechnical calls: Buy IVRCL, Cummins, sell Tata Motors
Here are your intra day picks for the day from various market experts and brokerage houses The post Technical calls: Buy IVRCL, Cummins, sell Tata Motors appeared first on Firstpost.
View ArticleStrides Arcolab gets USFDA approval for its sterile facility
Pharmaceutical firm Strides Arcolab said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Polish sterile facility. The post Strides Arcolab...
View ArticlePunters should make small bets till RBI action on 29 Jan
The market is waiting for a clear signal on decisive up or down moves. But the undertone is still bullish, and several stocks look ripe for a punt. The post Punters should make small bets till RBI...
View ArticleUS drug maker Mylan buys Strides Arcolab unit for $1.6 bn
Generic drugmaker Mylan said it will buy a unit of Strides Arcolab for $1.6 billion to expand its presence in the fast-growing injectable drugs market. The post US drug maker Mylan buys Strides Arcolab...
View ArticleIt’s a done deal: Mylan gets US nod to buy Strides’ unit Agila
The companies will have to divest assets needed to make 11 generic injectable drugs as a condition of approving the deal, the FTC said. The post It’s a done deal: Mylan gets US nod to buy Strides’ unit...
View ArticleAll-stock deal: India’s Strides Arcolab to buy Shasun Pharma for $200 mn
Generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal. The post All-stock deal: India’s Strides Arcolab to buy...
View ArticleFIPB to consider Kotak Bank’s FDI proposal on 28 May
India allows FDI in most of the sectors through automatic route, but in certain segments considered sensitive for the economy and security, the proposals have to be first cleared by FIPB. The post FIPB...
View ArticleStrides Arcolab to buy Aspen’s generics biz for Rs 1910 cr, shares rise 9%
The transaction will be financed by a combination of internal accruals and debt financing The post Strides Arcolab to buy Aspen’s generics biz for Rs 1910 cr, shares rise 9% appeared first on Firstpost.
View ArticleGovt approves FDI worth Rs 4,000 cr in pharma sector, Torrent Pharma, Syngene...
The government, however, rejected proposal of drug firm Strides Arcolab to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals and deferred three proposals from...
View Article